Marta Jarlier

2.1k total citations
64 papers, 1.3k citations indexed

About

Marta Jarlier is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Marta Jarlier has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Molecular Biology. Recurrent topics in Marta Jarlier's work include Pancreatic and Hepatic Oncology Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Cancer survivorship and care (8 papers). Marta Jarlier is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Cancer survivorship and care (8 papers). Marta Jarlier collaborates with scholars based in France, United States and United Kingdom. Marta Jarlier's co-authors include Philippe Rouanet, André Pèlegrin, Christel Larbouret, Thierry Chardès, Bruno Robert, H Sancho-Garnier, Pierre‐Emmanuel Colombo, Muriel Busson, Wilhem Leconet and Véronique Garambois and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Marta Jarlier

59 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Jarlier France	21	695	362	288	249	234	64	1.3k
François P. Duhoux Belgium	18	589 0.8×	318 0.9×	433 1.5×	140 0.6×	98 0.4×	92	1.2k
Ayman Oweida United States	19	694 1.0×	336 0.9×	125 0.4×	423 1.7×	104 0.4×	46	1.3k
Fernanda Herrera Switzerland	19	625 0.9×	216 0.6×	283 1.0×	257 1.0×	243 1.0×	65	1.6k
Turid Hellevik Norway	19	631 0.9×	524 1.4×	137 0.5×	329 1.3×	135 0.6×	26	1.4k
Brian M. Nolen United States	21	577 0.8×	547 1.5×	127 0.4×	282 1.1×	189 0.8×	28	1.6k
Matthew Simms United Kingdom	17	271 0.4×	409 1.1×	227 0.8×	145 0.6×	158 0.7×	41	1.2k
Hiroki Hayashi Japan	21	624 0.9×	360 1.0×	288 1.0×	110 0.4×	472 2.0×	78	1.2k
Rachel C. Brennan United States	21	463 0.7×	570 1.6×	124 0.4×	130 0.5×	109 0.5×	64	1.4k
Huimin Tian China	18	448 0.6×	313 0.9×	100 0.3×	360 1.4×	83 0.4×	34	1.0k
Laura Zanotti Italy	27	527 0.8×	546 1.5×	105 0.4×	150 0.6×	214 0.9×	76	1.9k

Countries citing papers authored by Marta Jarlier

Since Specialization

Citations

This map shows the geographic impact of Marta Jarlier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Jarlier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Jarlier more than expected).

Fields of papers citing papers by Marta Jarlier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Jarlier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Jarlier. The network helps show where Marta Jarlier may publish in the future.

Co-authorship network of co-authors of Marta Jarlier

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Jarlier. A scholar is included among the top collaborators of Marta Jarlier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Jarlier. Marta Jarlier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jarlier, Marta, et al.. (2025). Impact of an educational physiotherapy-yoga intervention on perceived stress in women treated with brachytherapy for cervical cancer: a randomised controlled mixed study protocol (KYOCOL). BMJ Open. 15(6). e098570–e098570.

Dolbeault, Sylvie, et al.. (2025). Accepting to Participate in an Early‐Phase Clinical Trial in Oncology: A Qualitative Study on the Patients' Experiences, Understanding, and Inner Motivations. Psycho-Oncology. 34(10). e70291–e70291.

Jarlier, Marta, et al.. (2024). Efficacy of a physiotherapy, yoga and patient education programme for patients with breast cancer and hormone therapy-induced pain: a multicentre randomised study protocol (SKYPE 2). BMJ Open. 14(1). e075378–e075378.

Mallavialle, Aude, Julien Faget, Lindsay B. Alcaraz, et al.. (2023). Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer. British Journal of Pharmacology. 183(6). 1288–1309. 9 indexed citations

Jarlier, Marta, et al.. (2023). Benefits of cardiac coherence combined with medical hypnosis on preoperative anxiety before cancer surgery: the COHEC II study trial protocol. BMJ Open. 13(12). e072215–e072215. 1 indexed citations

Carrier, Guillaume, Marta Jarlier, Johan Gagnière, et al.. (2022). Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE). BMJ Open. 12(12). e061527–e061527. 3 indexed citations

Quénet, François, Marta Jarlier, Sébastien Carrère, et al.. (2022). The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases. Surgery. 172(5). 1434–1441.

Denis, Vincent, Maguy Del Rio, Emmanuel Cornillot, et al.. (2022). Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells. PLoS ONE. 17(9). e0274390–e0274390. 6 indexed citations

Fiteni, Frédéric, et al.. (2021). Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients. Breast Cancer Research and Treatment. 186(3). 705–713. 12 indexed citations

10.

Fraisse, Julien, Marta Jarlier, Florence Boissière‐Michot, et al.. (2020). Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells. International Journal of Radiation Oncology*Biology*Physics. 106(5). 1039–1051. 8 indexed citations

11.

Andrade, Augusto Faria, Diégo Tosi, Henri‐Alexandre Michaud, et al.. (2019). Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( ATR ) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer. Cancer Research. 79(11). 2933–2946. 49 indexed citations

12.

Lozza, Catherine, Alexandre Pichard, Julie Constanzo, et al.. (2019). Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy. Clinical Cancer Research. 25(15). 4775–4790. 31 indexed citations

13.

Arnoult, Christophe, Thomas Bourquard, Marta Jarlier, et al.. (2019). A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions. mAbs. 11(3). 593–605. 20 indexed citations

14.

Fraisse, Julien, Hélène de Forges, Marta Jarlier, et al.. (2018). Effects of a Hypnosis Session Before General Anesthesia on Postoperative Outcomes in Patients Who Underwent Minor Breast Cancer Surgery. JAMA Network Open. 1(4). e181164–e181164. 39 indexed citations

15.

Leconet, Wilhem, Stanislas du Manoir, Clément Chevalier, et al.. (2016). Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis. Clinical Cancer Research. 23(11). 2806–2816. 87 indexed citations

16.

Marzi, Laetitia, Nadia Vié, Diégo Tosi, et al.. (2016). FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer. British Journal of Cancer. 115(10). 1223–1233. 44 indexed citations

17.

Boissière‐Michot, Florence, Gwendal Lazennec, Marta Jarlier, et al.. (2014). Characterization of an adaptive immune response in microsatellite-instable colorectal cancer. OncoImmunology. 3(6). e29256–e29256. 74 indexed citations

18.

Leconet, Wilhem, Christel Larbouret, Thierry Chardès, et al.. (2013). Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. Oncogene. 33(47). 5405–5414. 81 indexed citations

19.

Mangé, Alain, Jérôme Lacombe, Caroline Mollévi, et al.. (2012). Serum Autoantibody Signature of Ductal Carcinoma In Situ Progression to Invasive Breast Cancer. Clinical Cancer Research. 18(7). 1992–2000. 31 indexed citations

20.

Lacombe, Jérôme, Alain Mangé, Marta Jarlier, et al.. (2012). Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early‐stage breast cancers. International Journal of Cancer. 132(5). 1105–1113. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact